Comparison of hepatitis C treatment patterns in patients with and without psychiatric and/or substance use disorders

Journal of Viral Hepatitis

Volumn 13, Issue 4, 2006, Pages 235-241

  Chainuvati, S ^a,b   Khalid, S K ^a,b   Kancir, S ^b   Shea, M ^a,b   Edwards, J ^b   Sernyak, M ^a,b   Wongcharatrawee, S ^a,b   Garcia Tsao, G ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

Antiviral therapy; Hepatitis C; Psychiatric disorders; Substance use; Veterans

Indexed keywords

ANTIVIRUS AGENT; HEPATITIS C ANTIBODY; INTERFERON; PEGINTERFERON; RIBAVIRIN; VIRUS RNA;

ADULT; AGED; ANTIBODY DETECTION; ANXIETY; ARTHRALGIA; ARTICLE; BIPOLAR DISORDER; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DATA BASE; DEMOGRAPHY; DEPRESSION; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; FATIGUE; FEMALE; FREQUENCY ANALYSIS; HEALTH STATUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IRRITABILITY; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MENTAL DISEASE; MENTAL PATIENT; NAUSEA; NEUROPSYCHIATRY; PATIENT COMPLIANCE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RETINOPATHY; SCHIZOPHRENIA; SEIZURE; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SUBSTANCE ABUSE; TREATMENT INDICATION; VETERAN; VIOLENCE; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; COHORT STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; RNA, VIRAL; STATISTICS, NONPARAMETRIC; SUBSTANCE-RELATED DISORDERS; VETERANS; VIRAL LOAD;

EID: 33645058898     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2005.00681.x     Document Type: Article

References (31)

1. Alter MJ Kruszon-Moran D Nainan OV et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 1999 341 556 562
2. Kim WR The burden of hepatitis C in the United States Hepatology 2002 36 S30 S34
3. Cheung RC Epidemiology of hepatitis C virus infection in American veterans Am J Gastroenterol 2000 95 740 747
4. Austin GE Jensen B Leete J et al. Prevalence of hepatitis C virus seropositivity among hospitalized US veterans Am J Med Sci 2000 319 353 359
5. Briggs ME Baker C Hall R et al. Prevalence and risk factors for hepatitis C virus infection at an urban Veterans Administration medical center Hepatology 2001 34 1200 1205
6. Roselle GA Danko LH Kralovic SM et al. National hepatitis C surveillance day in the Veterans Health Administration of the Department of Veterans Affairs Mil Med 2002 167 756 759
7. Dominitz JA Boyko EJ Koepsell TD et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers Hepatology 2004 41 88 96
8. Manns MP McHutchison JG Gordon SC et al. Peginterferon alfa-2b in combination with ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: results of a randomised trial Lancet 2001 358 958 965
9. Fried MW Shiffman ML Reddy R et al. Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection New Engl J Med 2002 347 975 982
10. Hadziyannis SJ Sette H Jr. Morgan TR et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose Ann Intern Med 2004 140 346 355
11. National Institutes of Health National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002-June 10-12, 2002 Hepatology 2002 36 Suppl. 1 S3 S21
12. National Institutes of Health National Institutes of Health Consensus Development Conference Panel Statement: Management of Hepatitis C Hepatology 1997 26 2S 10S
13. EASL EASL International Consensus Conference on Hepatitis C: Consensus Statement J Hepatol 1999 30 956 961
14. Sherman M Management of viral hepatitis: clinical and public health perspectives - a consensus statement Can J Gastroenterol 1997 11 407 416
15. El-Serag HB Kunik M Richardson P et al. Psychiatric disorders among veterans with hepatitis C infection Gastroenterology 2002 123 476 482
16. Dinwiddie SH Shicker L Newman T Prevalence of hepatitis C among psychiatric patients in the public sector Am J Psychiatry 2003 160 172 174
17. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th edn Washington, DC American Psychiatric Press 1994
18. VA National Hepatitis C Program Treatment Recommendations for Patients with Chronic Hepatitis C Version 1.2 February 1999
19. Van Thiel DH Friedlander L Molloy PJ et al. Interferon-alpha can be used successfully in patients with hepatitis C virus positive chronic hepatitis who have a psychiatric illness Eur J Gastroenterol Hepatol 1995 7 165 168
20. Pariante CM Orru MG Baita A et al. Treatment with interferon-a in patients with chronic hepatitis and mood or anxiety disorders Lancet 1999 354 131 132
21. The French METAVIR Cooperative Study Group Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C Hepatology 1994 20 15 20
22. Ho SB Nguyen H Tetrick LL et al. Influence of psychiatric diagnoses on interferon-a treatment for chronic hepatitis C in a veteran population Am J Gastroenterol 2001 96 157 164
23. Cawthorne CH Rudat KR Burton MS et al. Limited success of HCV antiviral therapy in United States veterans Am J Gastroenterol 2002 97 149 155
24. Muir AJ Provenzale D A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection J Clin Gastroenterol 2002 34 268 271
25. Nguyen HA Miller AI Dieperink E et al. Spectrum of disease in U.S. veteran patients with hepatitis C Am J Gastroenterol 2002 97 1813 1820
26. McHutchison JG Manns M Patel K et al. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C Gastroenterology 2002 123 1061 1069
27. Schaefer M Schmidt F Folwaczny C et al. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups Hepatology 2003 37 443 451
28. McHutchison JG Gordon SC Schiff ER et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C N Engl J Med 1998 339 1485 1492
29. Poynard T Marcellin P Lee SS et al. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT) Lancet 1998 352 1426 1432
30. Morelli J Kim CY Willner IR U.S. veterans' experience with Rebetron in a non-study environment: success or failure? Am J Gastroenterol 2002 97 2379 2382
31. Reddy KR Hoofnagle JH Tong MJ et al. Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group Hepatology 1999 30 787 793